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Abstract
Enteric viruses infect the mammalian gastrointestinal tract which is home to a diverse community 
of intestinal bacteria. Accumulating evidence suggests that certain enteric viruses utilize these 
bacteria to promote infection. While this is not surprising considering their proximity, multiple 
viruses from different viral families have been shown to bind directly to bacteria or bacterial 
components to aid in viral replication, pathogenesis, and transmission. These data suggest that the 
concept of a single virus infecting a single cell, independent of the environment, needs to be 
reevaluated. In this review, I will discuss the current knowledge of enteric virus-bacterial 
interactions and discuss the implications for viral pathogenesis and transmission.
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Introduction
The microbiota is now widely recognized for being vital to human health (1). Consisting of 
bacteria, fungus, and viruses, the microbiota inhabit multiple sites on the human body where 
they have developed an ecological niche that is a benefit to both the host and colonizing 
organisms. Among these sites, the gastrointestinal tract (GI) is home to the most extensive 
collection of the microbiota, including a dense community of commensal bacteria. This 
diverse community is made up of approximately 1013 bacteria from 500-100 different 
species (2–4). A majority of these bacteria reside in the lower gastrointestinal tract, however, 
due to pH, oxygen, and nutrient availability, distinct bacterial populations inhabit both the 
small and large intestine (5). Further, intestinal bacteria vary amongst individuals and can be 
influenced by genetics, diet, and lifestyle (6–8). Additionally, imbalances in the microbial 
composition have been linked to many human diseases including inflammatory bowel 
diseases, type 2 diabetes, and obesity (9–14).
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Enteric viruses initiate infection in the mammalian GI tract where they encounter these 
microbiota. Previous data demonstrate that multiple enteric viruses utilize the microbiota to 
promote replication, pathogenesis, transmission. Many of these viruses have been shown to 
interact directly with intestinal bacteria, and in this review, I will highlight our latest 
understanding of the interaction between enteric viruses and intestinal bacteria and the 
consequences. Specifically, I will discuss the influence of bacteria on members of the 
picornavirus, reovirus, and retrovirus families. Additional enteric viruses also exploit the 
microbiota; however, these viruses will be discussed separately in this special volume. 
Overall these studies suggest that the conventional view of a single virus infecting a cell is 
too limited. Other factors, including the microbiota, need to be considered when 
investigating the outcome of viral infections in vivo.
Intestinal bacteria impact enteric viral infections
It comes to no surprise that, given the proximity of enteric viruses and intestinal bacteria, 
recent research indicates that bacteria can impact enteric viral infections. While these 
bacteria could impede viral infection by acting as a physical barrier in the intestine, recent 
compelling evidence has shown that some enteric viruses utilize bacteria to promote 
infection. Poliovirus, a non-enveloped enteric virus in the Picornaviridae family that initiates 
infection in the intestine, can disseminate to the central nervous system to cause paralytic 
poliomyelitis. In mice depleted of intestinal bacteria by antibiotics, poliovirus replication 
and lethality is significantly reduced compared to untreated mice (15). These data indicate 
that bacteria promote poliovirus intestinal replication and pathogenesis. Further, data reveal 
that poliovirus can bind to bacteria through interactions with bacterial surface components, 
lipopolysaccharide (LPS) and peptidoglycan, to enhance infectivity (16, 17).
Rotavirus, a non-enveloped RNA virus from the Reoviridae family, is a leading cause of 
diarrheal disease in children worldwide (18). Depletion of intestinal bacteria by antibiotics 
reduced diarrhea duration and rotavirus fecal shedding in mice (19). Further, germ-free mice 
also exhibit a delay in rotavirus fecal shedding, implicating a role for bacteria in rotavirus 
infection. Reovirus, another member of the Reoviridae family, also had reduced replication 
and pathogenesis when intestinal bacteria are depleted (15). Similar to poliovirus, both 
Grampositive and Gram-negative bacteria can bind and enhance reovirus infectivity (20). 
This interaction is likely facilitated by viral binding to LPS and peptidoglycan, suggesting 
that reovirus, like poliovirus, may utilize a broad array of different intestinal bacterial 
isolates to facilitate infection in the intestine.
Finally, mouse mammary tumor virus (MMTV) is an enveloped retrovirus that infects 
lymphoid cells in Peyer’s patches of the intestine (21). MMTV can establish persistence in 
mice and is transmitted from infected females to suckling pups in milk. Commensal bacteria 
are required to maintain viral persistence as the virus can be abolished in germ-free mice 
(22) Specifically, MMTV can bind to LPS via LPS-binding proteins that become integrated 
into the viral envelope during egress (23). Overall these data provide compelling evidence 
that some enteric viruses have evolved to utilize intestinal bacteria to promote infection.
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Bacteria enhance viral thermostability
Recent advances have shed light on the mechanistic outcome for these virus-bacterial 
interactions. Data suggest that enteric viruses bind to bacteria to stabilize the virion to retain 
infectivity. For example, both Gram-positive and Gram-negative bacteria enhance the 
thermostability of poliovirus (Fig. 1A) (15). Binding of poliovirus to LPS retain viral 
particles in their infectious state, limiting inactivation and premature release of viral RNA. 
(16). Further a mutation in the poliovirus VP1 capsid protein, T99K, reduces LPS binding 
and environmental fitness, suggesting that bacterial enhancement of thermostability may 
also play an essential role in viral transmission from host-to-host. These effects are also seen 
in other members of the Picornaviridae family as well. LPS and peptidoglycan enhance the 
thermostability of Coxsackievirus A21, Coxsackievirus B5, and Echovirus 30 (24), and 
bacteria improve the stability of Coxsackievirus B3, Aichi, and mengovirus during bleach 
treatment (25). Overall, these data suggest that bacterial-mediated enhancement of 
thermostability may be a shared mechanism for picornaviruses.
Similar to poliovirus, recent evidence suggests that bacteria also enhance the stability of 
reovirus. Both Gram-positive and Gram-negative bacteria improve reovirus thermostability 
in vitro through interactions with LPS and peptidoglycan (20). Furthermore, intermediate 
infectious subvirion particles (ISVPs) also are stabilized by LPS and peptidoglycan. These 
ISVPs are formed by proteolytic processing of the virion and required for attachment and 
entry of reovirus into host cells and contribute to intestinal infection (26–28). These data 
suggest that the binding site of these bacterial components to reovirus does not involve 
capsid proteins, μ1 or σ3, since they are either cleaved or absent on ISVPs. Interestingly, 
individual bacterial components have different effects on specific strains of reovirus. While 
LPS and peptidoglycan enhance have both the Type 1 Lang (TIL) and Type 3 Dearing (T3D) 
strains of reovirus, lipoteichoic acid and chitin only enhanced T3D thermostability, but not 
the TIL strain. Therefore, specific reovirus strains may have different affinities for distinct 
bacterial components; however, if these affinities affect strain-specific replication and 
pathogenesis differences remains unknown.
Bacteria enhance viral attachment to host cells
Another mechanism for bacterial-viral interactions is through enhancement of viral 
attachment to the host cell. In addition to enhancing poliovirus thermostability, incubation of 
poliovirus with bacteria increase attachment to poliovirus receptor (PVR)-expressing cells 
(Fig. 1B) (15). Evidence suggests that this enhancement is through direct interaction with 
the receptor since poliovirus, incubated with LPS, bound to significantly more purified PVR 
than virus incubated in PBS alone (16). Interestingly, the VP1-T99K poliovirus mutant, 
which reduces LPS binding, still retained LPS-mediated enhancement of cell attachment. 
These data suggest that the affinity and concentration of LPS molecules may influence 
poliovirus cell attachment and thermostability.
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Bacteria can facilitate viral co-infection and promote viral genetic 
recombination
In addition to the virion thermostability and cell attachment, Erickson et al. demonstrated 
that binding of poliovirus to specific bacterial strains increased viral co-infection of host 
cells (Fig. 1C) (17). Using DsRed- and GFP-expressing poliovirus, the authors found that 
poliovirus mixed with certain bacterial isolates increased the number of dual-infected HeLa 
cells. These data are not surprising since electron microscopy studies revealed that multiple 
poliovirus virions bound to a single bacterium. Interestingly, the increase in co-infection 
rates correlated with viral binding to bacterial isolates that had increased adherence to HeLa 
cells. Further, using drug- and temperature-sensitive poliovirus mutants, the authors found 
that bacterial enhancement of co-infection also increased the likelihood of genetic 
recombination amongst poliovirus virions. Overall, these data suggest that poliovirus may 
utilize bacteria to improve viral fitness in the mammalian GI tract through increased genetic 
recombination.
Bacteria promote viral immune evasion
Commensal bacteria provide vital stimulation to develop a mature host immune system (29, 
30). While these immune signals from bacteria promote colonization resistance to 
pathogenic organisms, evidence suggests that some enteric viruses have exploited these 
pathways to evade the immune system. For example, antibiotics enhance the antibody 
response to a rotavirus infection, suggesting that bacteria can modulate the immune response 
to rotavirus (19). The mechanism behind this response, however, is unclear. Similarly, 
MMTV can subvert the host immune response to establish persistence in mice. Immune 
evasion for MMTV requires functional Toll-like receptor 4 (TLR-4) signaling and the 
immunosuppressive cytokine IL-10; however, the mechanism was largely unclear (31). Kane 
et al. shed light on this mechanism when they demonstrated that MMTV uses commensal 
bacteria to facilitate persistence by binding to bacterial LPS (Fig. 1D) (22). To enable 
binding to LPS, MMTV incorporates LPS-binding factors, such as MD-2 and CD14, into the 
viral envelope during egress from infected cells (23). These LPS-binding factors play a 
critical role in the transfer of the LPS molecule to TLR-4 and can help trigger LPS-induced 
signaling pathways (32). Upon binding of LPS to the viral membrane, MMTV can stimulate 
the TLR-4 pathway leading to IL-6 production of the immunosuppressive IL-10 cytokine. 
This cascade activates an immune evasion pathway, facilitating persistent MMTV infections.
Negative or unclear effects of bacteria on enteric viruses
While this review focuses on the beneficial outcome of bacterial and viral interactions, these 
effects may not be conserved. Mouse adenovirus 1 does not require intestinal bacteria for 
intestinal infection (33). Additionally, defensins, host antimicrobial peptides induced in 
response to intestinal bacteria, can neutralize some adenoviruses types (34). Interestingly, 
recent data suggest that α-defensin may enhance mouse adenovirus type 2, a mouse enteric 
pathogen, suggesting that further work is necessary to determine the role of intestinal 
bacteria on enteric adenoviruses (35). Further, even though some experimental data suggest 
that intestinal bacteria may promote rotavirus infection, other data contradict this. For 
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example, probiotics have been shown to reduce the duration of viral diarrhea and 
administration of Lactobacillus rhamnosus GG reduces rotavirus shedding (36–38). 
Additionally, soluble factors from commensal bacteria can block rotavirus infection in vitro, 
and bacterial flagellin can eliminate chronic rotavirus infection through induction of IL-22 
and IL-18 in vivo (39). Overall, these data suggest that some enteric viruses may utilize 
intestinal bacteria to promote infection, while others may not.
Conclusions
Traditionally, viral infections have been viewed in the context of a single virus infecting a 
host cell. This straightforward view has allowed a reductionist approach to understanding the 
fundamental processes of the viral life cycle. This reductionist approach, however, does not 
always paint a full picture of the complex interactions that arise during a viral infection in 
vivo. In light of this potential complexity, recent evidence indicates that additional extrinsic 
factors, such the microbiota, may play a significant role in establishing a viral infection 
within a host. Overall, these new factors have established a new field of study in virology 
where viral infections are understood in the context of the environment for which they 
initiate infection. Future experiments identifying these complex interactions and their 
mechanisms need to be elucidated to provide a clear picture of the viral cycle, not only 
within the cell, but within the entire host.
In light of all these recent findings, there is clearly a need for more studies to understand 
how intestinal bacteria and the microbiota impact viral infections. Many questions remain as 
to the precise mechanisms of bacterial-mediated viral enhancement. First, which specific 
bacteria are required to enhance viral infection? Specific bacteria required to enhance 
infection for one enteric virus likely not enhance another. Data suggest that poliovirus and 
reovirus have different binding affinities to particular bacteria and bacterial components, and 
identifying the mechanism behind these binding affinities may provide potential therapeutic 
targets. Second, does biological sex influence these interactions? Microbiota differences 
between males and females exist and have been shown to influence type 1 diabetes in a 
mouse model (40). Recently, Coxsackievirus B3 replication in the intestine was shown to be 
sex-dependent (41). Since bacteria interact with Coxsackievirus B3 (25), perhaps sex-
dependent microbiota may influence viral replication through direct or indirect mechanisms. 
Third, do bacteria affect other non-enteric viruses? Data suggest that bacteria can affect the 
immune response to influenza virus (42–45); however, the impact of bacteria on other 
viruses is unclear. Since the bacteria colonize multiple sites on the human body, likely other 
viruses have interactions with bacteria. Additionally, viruses may play a complementary role 
in promoting bacterial infections (46); however, additional data is required to determine if 
this impacts infections in the gastrointestinal tract. Finally, what is the role of other 
components of the microbiota? Much of the current data has focused on the effect of the 
bacterial component of the microbiota on enteric viruses, but fungal inhabitants of the 
intestine and other viruses may also influence enteric viral infections as well. Additional 
studies are needed to investigate these interactions in the intestine to determine their 
influence on viral infection.
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Finally, it is important to note that while current data suggest that antibiotics may be an 
effective antiviral therapy, the side effects of disruption of commensal bacteria would largely 
outweigh any potential gain. Antiviral effects in mice require a substantial depletion of 
intestinal bacteria, with multiple antibiotics given prophylactically, which would likely 
disrupt the health benefits that these bacteria provide. Future experiments identifying 
specific interactions between enteric viruses and specific bacteria or bacterial components 
may offer a better opportunity for therapeutics. For example, the precise modulation of these 
virus-bacteria interactions may provide benefits in controlling outbreaks by disrupting viral 
transmission.
In conclusion, the role of the microbiota on enteric viruses represents a promising area of 
future study. It is imperative that this field moves forward so that we can truly understand the 
overall environmental factors that underlie a viral infection within a host. While we are only 
beginning to uncover the mechanisms behind interactions between enteric viruses and 
bacteria, I anticipate that future studies will continue to shed light on other factors of the 
microbiota that influence enteric viral infections. This knowledge will be vital as we 
continue to understand the complex interactions and environments within the human body 
that influence viral infections.
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Bacteria promote enteric virus infection. (A) The binding of bacteria to poliovirus and 
reovirus enhance thermostability. For poliovirus, enhanced thermostability limits premature 
release of viral RNA. Poliovirus and reovirus adapted from PBD 1HXS and 2CSE 
respectively. (B) Bacteria increase poliovirus binding to the poliovirus receptor on 
permissive cells. (C) Poliovirus bound to bacteria increase co-infection and genetic 
recombination between progeny virions. (D) MMTV bound to LPS induce an antiviral 
response to allow for viral persistence.
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